SVRA logo

Savara (SVRA) Company Overview

Profile

Full Name:

Savara Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 28, 2017

Indexes:

Not included

Description:

Savara Inc. is a biopharmaceutical company focused on developing innovative treatments for rare respiratory diseases. They specialize in inhaled therapies, aiming to improve the lives of patients with conditions like cystic fibrosis and pulmonary diseases through advanced drug delivery systems and clinical research.

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 26, 2010

Analyst ratings

Recent major analysts updates

Dec 20, 24 Wells Fargo
Overweight
Dec 19, 24 JMP Securities
Market Outperform
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Evercore ISI Group
In-Line
Oct 8, 24 HC Wainwright & Co.
Buy
Oct 1, 24 JMP Securities
Market Outperform
Oct 1, 24 HC Wainwright & Co.
Buy
Sep 9, 24 JMP Securities
Market Outperform
Aug 14, 24 HC Wainwright & Co.
Buy
Aug 13, 24 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Savara?
  • Does Savara pay dividends?
  • What sector is Savara in?
  • What industry is Savara in?
  • What country is Savara based in?
  • When did Savara go public?
  • Is Savara in the S&P 500?
  • Is Savara in the NASDAQ 100?
  • Is Savara in the Dow Jones?
  • When was Savara's last earnings report?
  • When does Savara report earnings?
  • Should I buy Savara stock now?

What is the ticker symbol for Savara?

The ticker symbol for Savara is NASDAQ:SVRA

Does Savara pay dividends?

No, Savara does not pay dividends

What sector is Savara in?

Savara is in the Healthcare sector

What industry is Savara in?

Savara is in the Biotechnology industry

What country is Savara based in?

Savara is headquartered in United States

When did Savara go public?

Savara's initial public offering (IPO) was on April 28, 2017

Is Savara in the S&P 500?

No, Savara is not included in the S&P 500 index

Is Savara in the NASDAQ 100?

No, Savara is not included in the NASDAQ 100 index

Is Savara in the Dow Jones?

No, Savara is not included in the Dow Jones index

When was Savara's last earnings report?

Savara's most recent earnings report was on Nov 12, 2024

When does Savara report earnings?

The next expected earnings date for Savara is May 9, 2025

Should I buy Savara stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions